Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2025

Mar 13, 2025

33003_dirs_2025-03-13_1dc759f1-8086-4f5a-9967-9fb6ebd0fba7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-03-11

Reporting Person: Kahn Clare (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-11 Common Stock P 1860 $5.3357 Acquired 2960 Direct